Redbud Labs

Redbud Labs develops affordable microfluidic technologies that reduce lab workflow complexity without sacrificing performance. We have developed NAxtract, a cartridge-based automated sample preparation platform that sets the bar for ease-of-use. Reagents are contained in a single, disposable cartridge, capable of processing 8 samples in 30 minutes. This platform disrupts the sample prep market by making automation accessible: small footprint, zero overhead, no setup, no service contracts. Our first cartridge performs pathogen extraction from human biofluids. The platform will feature a menu of cartridges, making NAxtract is the most reliable and affordable sample prep solution available across a range of markets...

Microfluidic mixing,microfluidics,point-of-care diagnostics,advanced microfluidic technologies,sample preparation,lab developed test,and nucleic acid extraction

Redbud labs operates in the Biotechnology research industry.

Redbud labs's revenue is 1m - 10m

Redbud labs has 11 - 50 employees.